Kelly Miller, MD
Interventional Cardiology · Glen Burnie, MDNPI 1205897287
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,497, 9.8 times the $256 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in MD, where the typical reported total is $7,370.
Across 177 payments — averaging $28.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- AOP Health US, LLC$1K
- Abbott$654
- Novartis$354
- Boehringer Ingelheim$244
- Inari Medical, Inc.$209
- plus $1K from 28 others
Across 2 payments — averaging $692.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1K
What the payments were for
- Food & beverage$5,042100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 49 | $1,146 |
| AOP Health US, LLC | 2 | $1,055 |
| Abbott | 29 | $654 |
| Novartis | 18 | $354 |
| Boehringer Ingelheim | 9 | $244 |
| Inari Medical, Inc. | 6 | $209 |
| Amgen | 7 | $148 |
| Pfizer | 7 | $138 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $136 |
| AstraZeneca | 5 | $106 |
| Bayer | 5 | $95 |
| Philips North America LLC | 3 | $81 |
| Stryker | 2 | $61 |
| Boston Scientific | 2 | $57 |
| Heartflow, Inc. | 3 | $56 |
| E.r. Squibb & Sons, L.L.C. | 3 | $54 |
| Biosense Webster, Inc. | 1 | $44 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $39 |
| Atricure, Inc. | 2 | $38 |
| Scpharmaceuticals Inc. | 2 | $32 |
| Novo Nordisk | 1 | $23 |
| Terumo Medical Corporation | 1 | $23 |
| Abiomed | 1 | $23 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Bridgebio Pharma, Inc. | 1 | $20 |
| Biotronik Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
| Kestra Medical Technology Services, Inc. | 1 | $16 |
| Vital Connect, Inc | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rapiblyk$2,111
- LINQ II$263
- VISA AF MRI VR SURESCAN$129
- FLOWTRIEVER CATHETER, S$103
- CT THROMBECTOMY SYSTEM KIT$103
How this compares
$5,042 in reported general payments places this provider in the 35th percentile of 71 interventional cardiology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 245 | $370,421 |
| XareltoRivaroxaban | 51 | $75,701 |
| JardianceEmpagliflozin | 25 | $36,545 |
| EntrestoSacubitril/Valsartan | 25 | $33,522 |
| NexletolBempedoic Acid | 24 | $19,476 |
| Repatha SureclickEvolocumab | 11 | $15,496 |
| Metoprolol Succinate | 685 | $14,118 |
| BrilintaTicagrelor | 17 | $13,747 |
| Rosuvastatin Calcium | 282 | $7,830 |
| Atorvastatin Calcium | 456 | $6,996 |
| Ranolazine ErRanolazine | 49 | $6,809 |
| Losartan Potassium | 258 | $3,518 |
| Ezetimibe | 74 | $3,487 |
| Lisinopril | 284 | $2,216 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 34 | $1,839 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $138 | $370,421245 claims |
| Johnson & JohnsonXarelto | $22 | $75,70151 claims |
| Boehringer IngelheimJardiance | $244 | $36,54525 claims |
| NovartisEntresto | $354 | $33,52225 claims |
| Esperion Therapeutics, Inc.Nexletol | $21 | $19,47624 claims |
| AstraZenecaBrilinta | $106 | $13,74717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 71 interventional cardiology providers in Maryland.
Other interventional cardiology in Glen Burnie
- Farrukh JalisiGlen Burnie$2K
- Vinay SatwahGreenbelt$679K
- Aloke FinnBaltimore$575K
- Michael ChenRockville$241K
- John WangBaltimore$138K
- Steven HearneSalisbury$100K
- Amir NajafiBel Air$82K
- Diljon ChahalBaltimore$78K
- Joseph CinderellaSalisbury$72K
- Ali TabrizchiBel Air$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.